Synendos Therapeutics AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2019-04-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.synendos.com
A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Synendos Therapeutics AG
- Target Recruit Count
- 90
- Registration Number
- NCT06670950
- Locations
- 🇬🇧
Richmond Pharmacology Ltd, London, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath